Benchmark maintains its buy rating on MSTR with a price target of $650. As of Monday, MicroStrategy purchased a further 2,530 ...

Elon Musk is being sued by the U.S. Securities and Exchange Commission over his 2022 Twitter takeover. The agency alleges ...

Elon Musk is being sued by the U.S. Securities and Exchange Commission, claiming he didn't disclose purchases of Twitter ...

The SEC sued Elon Musk, accusing the X owner of failing to properly disclose his purchases of Twitter stock in 2022.

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

Blaize (BZAI) and BurTech Acquisition Corp announced that they expect to complete their previously announced business combination on January 12. The combined company will be named ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The US Securities and Exchange Commission sued Elon Musk on Tuesday for failing to properly disclose his ownership of X, then ...

In total, Musk underpaid Twitter investors by more than $150 million for his purchases of Twitter common stock during this ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to ...

Richard S. Mahoney, the Chief Revenue Officer of Synopsys Inc . (NASDAQ:SNPS), a $80.47 billion market cap company currently trading at $522.66, recently executed a series of stock transactions, as ...

The U.S. Securities and Exchange Commission is suing Elon Musk for allegedly failing to properly disclose his purchase of ...